- Stock: IN STOCK
- Brand: DEUS MEDICAL
- Reward Points: RECEIVE 20 REWARD POINTS
- Model: TIRZEPATIDE
- Review count: 2 , Add testimonial
- Average rating: 5
Tirzepatide (GIP/GLP-1) — research peptide
Tirzepatide is a dual GIP and GLP-1 receptor agonist, one of the most-studied peptides in metabolic and body-composition research for its action across two incretin pathways at once. That dual mechanism is exactly what distinguishes it from single-agonist GLP-1 peptides. HelixaMed supplies tirzepatide lyophilised and lab-verified for identity and concentration.
Like all peptides it is delicate: freeze-dried on arrival, reconstituted with bacteriostatic water and stored cold to stay stable. Our reconstitution guide covers correct handling so a study runs on accurate material. This is a research-use compound only; no dosing or human-use instructions are provided.
- Dual agonist: GIP and GLP-1 pathways together.
- Metabolic research: a leading incretin peptide.
- Verified: lyophilised, batch-analysed.
What is Tirzepatide (GIP and GLP-1 Receptor Agonist)?
Tirzepatide is a novel peptide-based medication that acts as a dual agonist for GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. These receptors play critical roles in regulating blood sugar levels, and Tirzepatide's dual action enhances the body’s ability to control glucose, especially in individuals with Type 2 diabetes. It also has strong weight-loss effects due to its impact on appetite regulation and metabolism.
Tirzepatide Benefits
Tirzepatide offers a wide range of therapeutic effects, including:
Blood Sugar Regulation: Enhances insulin secretion and reduces glucagon release, leading to improved glucose control, especially in individuals with diabetes.
Weight Loss: It has demonstrated remarkable effects on weight reduction by regulating appetite and metabolism, making it effective for both diabetic and non-diabetic individuals.
Improved Cardiovascular Health: Tirzepatide may help reduce cardiovascular risks by improving cholesterol levels and lowering blood pressure.
Anti-inflammatory Properties: It has been found to reduce inflammation, which may benefit individuals suffering from chronic inflammatory conditions like diabetes.
ALSO KNOWN AS:
GIP and GLP-1 Receptor Agonist
Tirzepatide
Tirzepatide (GIP and GLP-1 Receptor Agonist) DOSAGE:
Tirzepatide (GIP and GLP-1 Receptor Agonist) 10mg/vial
Tirzepatide PEPTIDE INJECTIONS PACKAGE CONTENT:
1 Box of 1 Vial
HOW TO USE Tirzepatide PEPTIDE:
Tirzepatide is injected subcutaneously, generally once per week. The dosage should be adjusted based on blood glucose control and side effects, with weekly monitoring by a healthcare provider to optimize treatment.